Iron as a risk factor in neurological diseases

Hyperfine Interactions

Volumn 182, Issue 1-3, 2008, Pages 31-44

  Galazka Friedman, Jolanta ^a  

^a WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Brain iron; Electron microscopy; ELISA; M ssbauer spectroscopy; Oxidative stress

Indexed keywords

EID: 55449135870     PISSN: 03043843     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10751-008-9723-8     Document Type: Conference Paper

References (36)

1. E.R. Bauminger M. Barcikowska A. Friedman J. Gała̧zka- Friedman D. Hechel I. Nowik 1994 Does iron play a role in Parkinson's disease? Hyperfine Interact Hyperfine Interact. 91 853 856
2. J. Gała̧zka-Friedman E.R. Bauminger A. Friedman M. Barcikowska D. Hechel I. Nowik 1996 Iron in parkinsonian and control substantia nigra-A Mössbauer spectroscopy study Mov. Disord. 11 8 16
3. J. Gała̧zka-Friedman A. Friedman 1997 Controversies about iron in parkinsonian and control substantia nigra Acta Neurobiol. Exp. 57 210 225
4. J. Gała̧zka-Friedman E.R. Bauminger T. Tymosz A. Friedman 1998 Mössbauer spectroscopy, electron microscopy and electron diffraction studies of ferritin-like iron in human heart, liver and brain Hyperfine Interact. 3 49 52
5. A. Friedman J. Gała̧zka-Friedman 2001 The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress Adv. Neurol. 86 137 142
6. J. Galazka-Friedman E.R. Bauminger A. Friedman 2002 Iron in Parkinson's disease-Revisited Hyperfine Interact. 141/142 267 271
7. J. Galazka-Friedman E.R. Bauminger D. Koziorowski A. Friedman 2004 Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra Biochim. Biophys. Acta 1688 130 136
8. J. Galazka-Friedman E.R. Bauminger A. Friedman D. Koziorowski K. Szlachta 2005 Human nigral and liver iron-Comparison by Mössbauer spectroscopy, electron microscopy and ELISA Hyperfine Interact. 165 285 288
9. Friedman, A., Galazka-Friedman, J., Bauminger, E.R.: Iron as a trigger of neurodegeneration in Parkinson's disease. In: Koller, W., Melamed, E. (eds.) Handbook of Clinical Neurology. Parkinson's Disease and Related Disorders, vol. 83, p. 493. Elsevier (2007). ISBN 0444519009
10. J.M. Williams S.C. Andrew A. Treffry P.M. Harrison 1986 The relationship between ferritin and haemosiderin Hyperfine Interact. 29 1447 1450
11. M.B.H. Youdim D. Ben-Shachar P. Riederer 1989 Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol. Scand. 126 47 54
12. E. Sofic P. Riederer H. Heinsen H. Beckmann G.P. Reynolds G. Hebenstreit M.B.H. Youdim 1988 Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain J Neural. Trans. 74 199 205
13. A. Friedman J. Galazka-Friedman E.R. Bauminger Z.K. Wszolek J. Słowiński D.W. Dickson 2006 Iron as a possible cause of oxidative stress injury in progressive supranuclear palsy-Preliminary results of Mössbauer spectroscopy study Mov. Disord. 21 suppl 15 S343
14. B. Hallgren P. Sourander 1958 The effect of age on the non-haemin iron the human brain J. Neurochem. 3 41 51
15. K.M. Earle 1968 Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue J. Neuropathol. Exp. Neurol. 27 1 13
16. L. Zecca H.M. Swartz 1993 Total and paramagnetic metals in human substantia nigra and its neuromelanin J. Neural. Trans. [P-D Sect] 5 203 213
17. P.D. Griffiths A.R. Crossman 1993 Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease Dementia 4 61 65
18. V.M. Mann J.M. Cooper S.E. Daniel K. Srai P. Jenner C.D. Marsden A.H.V. Schapira 1994 Complex I, iron, and ferritin in Parkinson's disease substantia nigra Ann. Neurol. 36 876 881
19. D.A. Loeffler J.R. Connor P.I. Juneau B.S. Snyder L. Kanaley A.J. DeMaggio H. Nguyen C.M. Brickman P.A. LeWitt 1995 Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions J. Neurochem. 65 710 716
20. L. Zecca M. Gallorini V. Schuenemann A.X. Trautwein M. Gerlach P. Riederer P. Vezzoni D. Tampellini 2001 Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes J. Neurochem. 76 1766 1773
21. L. Zecca A. Stroppolo A. Gatti D. Tampellini M. Toscani M. Gallorini G. Giaveri P. Arosio P. Santambrogio R.G. Fariello E. Karatekin M.H. Kleinman N. Turro O. Hornykiewicz F.A. Zucca 2004 The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging Proc. Natl. Acad. Sci. U. S. A. 101 9843 9848
22. L. Zecca D. Berg T. Arzberger P. Ruprecht W.D. Rausch M. Musicco D. Tampellini P. Riederer M. Gerlach G. Becker 2005 In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage Mov. Disord. 10 1278 1285
23. D.T. Dexter F.R. Wells A.J. Lees F. Agid Y. Agid P. Jenner C.D. Marsden 1989 Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease J. Neurochem. 52 1830 1836
24. R.J. Uitti A.H. Rajput B. Rozdilsky M. Bickis T. Wollin W.K. Yuen 1989 Regional metal concentrations in Parkinson's disease, other chronic neurological disease, and control brains Can. J. Neurol. Sci. 16 310 314
25. M. Gerlach A.X. Trautwein L. Zecca M.B.H. Youdim P. Riederer 1995 Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra J. Neurochem. 65 923 926
26. R.V. Morris G. Klingelhoefer R.L. Korotev T.D. Shelfer 1998 Mössbauer mineralogy on the Moon: The lunar regolith Hyperfine Interact. 117 405 432
27. J.R. Connor B.S. Snyder P. Arosio D.A. Loeffler P. A LeWitt 1995 quantitative analysis of isoferritins in selected regions of aged, parkinsonian and Alzheimer's diseased brains J. Neurochem. 65 717 724
28. P.M. Harrison P. Arosio 1996 The ferritins: molecular properties, iron storage function and cellular regulation Biochim. Biophys. Acta 1275 161 203
29. D. Berg H. Hochstrasser 2006 Iron metabolism in Parkinsonian syndromes Mov. Disord. 21 1299 1310
30. D. Koziorowski A. Friedman P. Arosio P. Santambrogio D. Dziewulska 2007 ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and Incidental Lewy Body compared to control Park. Rel. Disord. 13 214
31. A. Friedman J. Galazka-Friedman E.R. Bauminger D. Koziorowski 2006 Iron and ferritin in hippocampal cortex and substantia nigra in human brain-Implications for the possible role of iron in dementia J. Neurol. Sci. 248 31 34
32. M. Szczerbowska-Boruchowska M. Lankosz J. Stachowicz D. Adamek A. Krygowska-Wajs B. Tornik A. Szczudlik A. Simionovici S. Bohic 2004 Topographic and quantitative microanalysis of human central nervous system tissue using synchrotron radiation X-ray Spectrom. 33 3 11
33. M. Szczerbowska-Boruchowska J. Chwiej M. Lankosz D. Adamek S. Wójcik A. Krygowska-Wajs B. Tornik S. Bohic J. Susini A. Simionovici P. Dumas M. Kastyak 2005 Intraneuronal investigations of organic components and trace elements with the use of synchrotron radiation X-ray Spectrom. 34 514 520
34. M. Szczerbowska-Boruchowska P. Dumas M. Kastyak J. Chwiej M. Lankosz D. Adamek A. Krygowska-Wajs 2007 Biomolecular investigation of human substantia nigra in Parkinson's disease by synchrotron radiation Fourier transform infrared microspectroscopy Arch. Biochem. Biophys. 459 241 248
35. J. Chwiej D. Adamek M. Szczerbowska-Boruchowska A. Krygowska-Wajs S. Wójcik G. Falkenberg A. Manka M. Lankosz 2007 Investigations of differences in iron oxidation state inside single neurons from substantia nigra of Parkinson's disease and control patients using the micro-XANES technique J. Biol. Inorg. Chem. 12 204 211
36. O. Kakhlon Z.J. Cabantchik 2002 The labile iron pool: characterization, measurement, and participation in cellular processes(1) Free Radic. Biol. Med. 33 1037 1046